| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/29/2002 | US20020119566 Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules |
| 08/29/2002 | US20020119565 Isolation and use of solid tumor stem cells |
| 08/29/2002 | US20020119564 Selecting cells that express a known marker, such as proteins expressed by genes encoding the major histocomatibility complex |
| 08/29/2002 | US20020119563 Diunsaturated organic compounds as tissue crosslinking agents |
| 08/29/2002 | US20020119562 Method for selecting improved vectors |
| 08/29/2002 | US20020119558 Systems for sorting sperm via flow cytometry for sex-specific and low dose efforts at artificial insemination; animal husbandry |
| 08/29/2002 | US20020119554 Arginase II |
| 08/29/2002 | US20020119548 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/29/2002 | US20020119545 Isolated mammalian nucleic acid molecule encoding a receptor protein tyrosine kinase expressed in primitive hematopcietic cells and not expressed in mature hematopoietic cells |
| 08/29/2002 | US20020119530 Method of increasing product expression through solute stress |
| 08/29/2002 | US20020119526 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction |
| 08/29/2002 | US20020119525 TAB1 protein and DNA coding therefore |
| 08/29/2002 | US20020119524 Novel molecules of the T129-related protein family and uses thereof |
| 08/29/2002 | US20020119521 Expression vector or use as tools in gene therapy |
| 08/29/2002 | US20020119519 Nucleotide sequences coding preferential polyeptide for use in the treatment of cancer, kidney and respiratory disorders |
| 08/29/2002 | US20020119518 Peptide for use in treatment and diagnosis of heart defects |
| 08/29/2002 | US20020119517 Detection of modulators of body weight; obtain cell samples, monitor expression of preferenial genes, incubate with modulators, compare to control, monitor adjustment in body weight |
| 08/29/2002 | US20020119504 Antibody or antigen-binding sequences for use in the treatment of inflammatory bowel disease |
| 08/29/2002 | US20020119495 Immunogenic composition of hepatitis C and methods of use thereof |
| 08/29/2002 | US20020119471 Diagnosing allergic contact dermatitis in humans; obtain cells, isolate nucleotide sequences coding interleukins, monitor expression of interleukin polypeptide |
| 08/29/2002 | US20020119461 High fidelity polymerases and uses thereof |
| 08/29/2002 | US20020119445 Genetic engineering; prophylactic therapy |
| 08/29/2002 | US20020119189 Nucleosome-based anti-tumor compositions |
| 08/29/2002 | US20020119158 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 08/29/2002 | US20020119153 Antibody conjugate formulations for selectively inhibiting VEGF |
| 08/29/2002 | US20020119130 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/29/2002 | US20020119126 Culturing adipose stromal cells in a medium capable of supporting the growth of fibroblasts and differentiation inducing amounts of beta - glycerophosphate and ascorbic acid and/or ascorbic-2 phosphate |
| 08/29/2002 | US20020119125 Microencapsulated pheochromocyte of ox adrenal medulla as medicine for curing pain |
| 08/29/2002 | US20020119121 Compositions and methods for inducing specific cytolytic T cell responses |
| 08/29/2002 | US20020119119 Administering natural killer cell activating cytokine or flavonoid, wherein cytokine is not IL-2 or IFN-alpha; administering histamine or serotonin or H2 receptor agonists to inhibit production or release of hydrogen peroxide |
| 08/29/2002 | CA2698079A1 A cell therapy method for the treatment of tumors |
| 08/29/2002 | CA2576136A1 Novel calcium-independent phospholipases a2, genes thereof and promoter of the same |
| 08/29/2002 | CA2445796A1 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 08/29/2002 | CA2441444A1 Novel ecdysone receptor/invertebrate retinoid x receptor-based inducible gene expression system |
| 08/29/2002 | CA2438818A1 Rapid production of monoclonal antibodies |
| 08/29/2002 | CA2438775A1 T cell receptor variants expressed in mesenchymal cells and uses thereof |
| 08/29/2002 | CA2438769A1 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
| 08/29/2002 | CA2438754A1 A cell therapy method for the treatment of tumors |
| 08/29/2002 | CA2438390A1 Methods of modifying eukaryotic cells |
| 08/29/2002 | CA2438371A1 Histidine phosphatase interacting protein of 120 kd |
| 08/29/2002 | CA2438369A1 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade |
| 08/29/2002 | CA2438245A1 Treatment involving dkk-1 or antagonists thereof |
| 08/29/2002 | CA2438235A1 Neurotransmission-associated proteins |
| 08/29/2002 | CA2438148A1 Chemically defined medium for cultured mammalian cells |
| 08/29/2002 | CA2438133A1 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 08/29/2002 | CA2438119A1 Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system |
| 08/29/2002 | CA2437980A1 Methods of treating inflammation, particularly diabetes |
| 08/29/2002 | CA2437529A1 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 08/29/2002 | CA2437161A1 Anti-interferon-.alpha. antibodies |
| 08/29/2002 | CA2436516A1 Pg-3 and biallelic markers thereof |
| 08/29/2002 | CA2434652A1 Type 2 cytokine receptor and nucleic acids encoding same |
| 08/29/2002 | CA2433841A1 Gmg-3, gmg-4, and gmg-6 polynucleotides and polypeptides and uses thereof |
| 08/29/2002 | CA2432375A1 Lipolytic enzyme genes |
| 08/28/2002 | EP1235073A1 cGMP-VISUALIZING PROBE AND METHOD OF DETECTING AND QUANTIFYING cGMP BY USING THE SAME |
| 08/28/2002 | EP1234879A2 Human nucleic acid sequences from prostate tumour tissue |
| 08/28/2002 | EP1234188A2 Protein kinase regulation |
| 08/28/2002 | EP1234046A2 Udp-glucose:aglycon-glucosyltransferase |
| 08/28/2002 | EP1234045A2 Maize mip synthase promoter |
| 08/28/2002 | EP1234040A2 Hbv sequences |
| 08/28/2002 | EP1234037A2 DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE |
| 08/28/2002 | EP1234035A1 Human cytokine receptor |
| 08/28/2002 | EP1234034A1 Transfer compounds, the production and the use thereof |
| 08/28/2002 | EP1234030A2 18 human secreted proteins |
| 08/28/2002 | EP1234027A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 08/28/2002 | EP1234026A1 Method and apparatus for selectively targeting specific cells within a cell population |
| 08/28/2002 | EP1234025A1 Human enzymes of the metalloprotease family |
| 08/28/2002 | EP1234022A2 Dna recombination in eukaryotic cells by the bacteriophage phic31 recombination system |
| 08/28/2002 | EP1234021A2 Methods and compositions for enhancing developmental potential of oocytes and zygotes |
| 08/28/2002 | EP1233983A2 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 08/28/2002 | EP1233982A2 Novel hcv non-structural polypeptide |
| 08/28/2002 | EP1233981A1 G-protein coupled receptor |
| 08/28/2002 | EP1233980A2 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 08/28/2002 | EP1233975A1 29 human secreted proteins |
| 08/28/2002 | EP1233974A2 37 staphylococcus aureus genes and polypeptides |
| 08/28/2002 | EP1233783A2 Hbv/hcv virus-like particle |
| 08/28/2002 | EP1233780A1 Identification of sortase gene |
| 08/28/2002 | EP1233777A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 08/28/2002 | EP1141270A4 Ethylene-response-factor1 (erf1) in plants |
| 08/28/2002 | EP1105732A4 Agarose format for mammalian cell based reporter assays |
| 08/28/2002 | EP1019489A4 Application of shear flow stress to chondrocytes |
| 08/28/2002 | EP1005534A4 Method for increasing the efficiency of recombinant aav production |
| 08/28/2002 | EP1005374A4 Microparticles for delivery of nucleic acid |
| 08/28/2002 | EP0863990B1 Use of anti-sense sequences to increase responsiveness to gene amplification |
| 08/28/2002 | EP0853664A4 Colloidal silica films for cell culture |
| 08/28/2002 | EP0827591B1 Method for diagnosing chlamydia using an extracellular biological fluid |
| 08/28/2002 | EP0821727A4 Method for producing a highly enriched population of osteoclast cells |
| 08/28/2002 | CN1366045A Inducible promoter of fungus |
| 08/28/2002 | CN1366039A Human marrow-interstitial stem cell and its preparing process |
| 08/28/2002 | CN1089802C Monoclone antibody cell strain and its monoclone antibody with hepatitis C virus resisting non-structure zone 4 antigen |
| 08/27/2002 | US6441279 Inbred corn line G1900 |
| 08/27/2002 | US6441138 Protein which induces interferon-γ production by immunocompetent cell |
| 08/27/2002 | US6441137 Tie-2 ligands; tie= ?tyrosine kinase with ig (immunoglobulins) and egf (epidermal growth factor) homology domains?; tumor neovascularization |
| 08/27/2002 | US6440935 Such as cecropins and sarcotoxins |
| 08/27/2002 | US6440742 Recombinant AAV vector-based transduction system and use of same |
| 08/27/2002 | US6440741 Expression vector for consistent cellular expression of the tet on repressor in multiple cell types |
| 08/27/2002 | US6440740 Using silk fibroin |
| 08/27/2002 | US6440736 Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules |
| 08/27/2002 | US6440735 Dendritic cell vaccine containing telomerase reverse transcriptase for the treament of cancer |
| 08/27/2002 | US6440734 Insertion into porous solid matrix |
| 08/27/2002 | US6440732 Checkpoint/repair genes involved with dna repair prior to replication; aging resistance; cancer therapy |